These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17314517)

  • 1. Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine.
    Yamamoto JK; Pu R; Sato E; Hohdatsu T
    AIDS; 2007 Mar; 21(5):547-63. PubMed ID: 17314517
    [No Abstract]   [Full Text] [Related]  

  • 2. Feline immunodeficiency virus as a model for AIDS vaccination.
    Jarrett O; Yamamoto JK; Neil JC
    AIDS; 1990; 4 Suppl 1():S163-5. PubMed ID: 1967108
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccination against the feline immunodeficiency virus: the road not taken.
    Lecollinet S; Richardson J
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):167-90. PubMed ID: 17706778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of a vaccine against feline immunodeficiency virus.
    Hosie MJ
    Br Vet J; 1994; 150(1):25-39. PubMed ID: 8025833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FIV and HIV vaccines--problems and prospects.
    Harbour DA
    Br Vet J; 1994; 150(1):7-8. PubMed ID: 8025838
    [No Abstract]   [Full Text] [Related]  

  • 6. Lessons from the cat: development of vaccines against lentiviruses.
    Dunham SP
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):67-77. PubMed ID: 16678276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine protection against feline immunodeficiency virus: setting the challenge.
    Zwijnenberg R; Yamamoto JK
    Aust Vet J; 2007 Jun; 85(6):210-1. PubMed ID: 17547630
    [No Abstract]   [Full Text] [Related]  

  • 8. Feline immunodeficiency virus infection--causative agent of an acquired immunodeficiency syndrome in cats.
    Hartmann K
    Eur J Med Res; 1996 Nov; 1(12):547-50. PubMed ID: 9438159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward vaccination against feline leukemia virus and feline immunodeficiency virus infections.
    Osterhaus AD; Weijer K; Siebelink KH; Rimmelzwaan GF; Bosch ML
    J Am Vet Med Assoc; 1991 Nov; 199(10):1443-6. PubMed ID: 1666100
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vaccination against feline retrovirus infections].
    Horzinek MC
    Tierarztl Prax; 1996 Apr; 24(2):197-202. PubMed ID: 8650690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus.
    Dunham SP; Bruce J; Klein D; Flynn JN; Golder MC; MacDonald S; Jarrett O; Neil JC
    Vaccine; 2006 Nov; 24(49-50):7095-108. PubMed ID: 17049683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feline immunodeficiency virus infection: a valuable model to study HIV-1 associated encephalitis.
    Fletcher NF; Brayden DJ; Brankin B; Callanan JJ
    Vet Immunol Immunopathol; 2008 May; 123(1-2):134-7. PubMed ID: 18289700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panel report on the colloquium on feline leukemia virus/feline immunodeficiency virus: tests and vaccination.
    J Am Vet Med Assoc; 1991 Nov; 199(10):1273-7. PubMed ID: 1666068
    [No Abstract]   [Full Text] [Related]  

  • 14. FIV infection of the domestic cat: an animal model for AIDS.
    Willett BJ; Flynn JN; Hosie MJ
    Immunol Today; 1997 Apr; 18(4):182-9. PubMed ID: 9136455
    [No Abstract]   [Full Text] [Related]  

  • 15. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.
    Kusuhara H; Hohdatsu T; Okumura M; Sato K; Suzuki Y; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
    Vet Microbiol; 2005 Jul; 108(3-4):155-65. PubMed ID: 15899558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of vaccination strategies against infection with feline immunodeficiency virus (FIV) based on recombinant viral vectors expressing FIV Rev and OrfA.
    Huisman W; Schrauwen EJ; Tijhaar E; Süzer Y; Pas SD; van Amerongen G; Sutter G; Rimmelzwaan GF; Osterhaus AD
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):332-8. PubMed ID: 18952300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel approaches to vaccination against the feline immunodeficiency virus.
    Pistello M; Conti F; Vannucci L; Freer G
    Vet Immunol Immunopathol; 2010 Mar; 134(1-2):48-53. PubMed ID: 19896725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deluge of questions prompts AAFP to develop FIV vaccine brief. American Association of Feline Practitioners.
    Kahler SC;
    J Am Vet Med Assoc; 2002 Nov; 221(9):1231-4. PubMed ID: 12418682
    [No Abstract]   [Full Text] [Related]  

  • 19. New challenges for the diagnosis of feline immunodeficiency virus infection.
    Crawford PC; Levy JK
    Vet Clin North Am Small Anim Pract; 2007 Mar; 37(2):335-50, vii. PubMed ID: 17336678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Models for AIDS pathogenesis: simian immunodeficiency virus, simian-human immunodeficiency virus and feline immunodeficiency virus infections.
    Overbaugh J; Luciw PA; Hoover EA
    AIDS; 1997; 11 Suppl A():S47-54. PubMed ID: 9451965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.